131 related articles for article (PubMed ID: 8938739)
1. Adenovirus-mediated over-expression of interleukin-1 receptor antagonist reduces susceptibility to excitotoxic brain injury in perinatal rats.
Hagan P; Barks JD; Yabut M; Davidson BL; Roessler B; Silverstein FS
Neuroscience; 1996 Dec; 75(4):1033-45. PubMed ID: 8938739
[TBL] [Abstract][Full Text] [Related]
2. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats.
Barks JD; Liu XH; Sun R; Silverstein FS
Neuroscience; 1997 Jan; 76(2):397-409. PubMed ID: 9015325
[TBL] [Abstract][Full Text] [Related]
3. Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats.
Wang P; Barks JD; Silverstein FS
Neuroscience; 1999 Jan; 88(2):585-97. PubMed ID: 10197777
[TBL] [Abstract][Full Text] [Related]
4. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats.
McDonald JW; Silverstein FS; Cardona D; Hudson C; Chen R; Johnston MV
Neuroscience; 1990; 36(3):589-99. PubMed ID: 2234402
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-a attenuates N-methyl-D-aspartate-mediated neurotoxicity in neonatal rat hippocampus.
Liu XH; Xu H; Barks JD
Brain Res; 1999 Dec; 851(1-2):94-104. PubMed ID: 10642832
[TBL] [Abstract][Full Text] [Related]
6. Intracerebral NMDA injection stimulates production of interleukin-1 beta in perinatal rat brain.
Hagan P; Poole S; Bristow AF; Tilders F; Silverstein FS
J Neurochem; 1996 Nov; 67(5):2215-8. PubMed ID: 8863535
[TBL] [Abstract][Full Text] [Related]
7. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
8. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat.
Liu XH; Eun BL; Silverstein FS; Barks JD
Pediatr Res; 1996 Dec; 40(6):797-803. PubMed ID: 8947953
[TBL] [Abstract][Full Text] [Related]
9. MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats.
McDonald JW; Silverstein FS; Johnston MV
Neuroscience; 1990; 38(1):103-13. PubMed ID: 2255390
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development.
McDonald JW; Trescher WH; Johnston MV
Brain Res; 1992 Jun; 583(1-2):54-70. PubMed ID: 1380402
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain.
Betz AL; Yang GY; Davidson BL
J Cereb Blood Flow Metab; 1995 Jul; 15(4):547-51. PubMed ID: 7790404
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TNF-alpha can attenuate or exacerbate excitotoxic injury in neonatal rat brain.
Galasso JM; Wang P; Martin D; Silverstein FS
Neuroreport; 2000 Feb; 11(2):231-5. PubMed ID: 10674461
[TBL] [Abstract][Full Text] [Related]
13. The non-competitive AMPA antagonist LY 300168 (GYKI 53655) attenuates AMPA-induced hippocampal injury in neonatal rodents.
Liu XH; Wang P; Barks JD
Neurosci Lett; 1997 Oct; 235(1-2):93-7. PubMed ID: 9389604
[TBL] [Abstract][Full Text] [Related]
14. Early appearance of functional deficits after neonatal excitotoxic and hypoxic-ischemic injury: fragile recovery after development and role of the NMDA receptor.
Felt BT; Schallert T; Shao J; Liu Y; Li X; Barks JD
Dev Neurosci; 2002; 24(5):418-25. PubMed ID: 12640181
[TBL] [Abstract][Full Text] [Related]
15. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat.
Stroemer RP; Rothwell NJ
J Cereb Blood Flow Metab; 1998 Aug; 18(8):833-9. PubMed ID: 9701344
[TBL] [Abstract][Full Text] [Related]
16. Excitotoxic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain.
Szaflarski J; Ivacko J; Liu XH; Warren JS; Silverstein FS
Brain Res Mol Brain Res; 1998 Apr; 55(2):306-14. PubMed ID: 9582443
[TBL] [Abstract][Full Text] [Related]
17. Human FGF-1 gene delivery protects against quinolinate-induced striatal and hippocampal injury in neonatal rats.
Hossain MA; Fielding KE; Trescher WH; Ho T; Wilson MA; Laterra J
Eur J Neurosci; 1998 Aug; 10(8):2490-9. PubMed ID: 9767380
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate-mediated injury enhances quisqualic acid-stimulated phosphoinositide turnover in perinatal rats.
Chen CK; Silverstein FS; Johnston MV
J Neurochem; 1992 Sep; 59(3):963-71. PubMed ID: 1322976
[TBL] [Abstract][Full Text] [Related]
19. Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats.
Galasso JM; Harrison JK; Silverstein FS
Am J Pathol; 1998 Nov; 153(5):1631-40. PubMed ID: 9811356
[TBL] [Abstract][Full Text] [Related]
20. HA-966 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces N-methyl-D-aspartate (NMDA)-mediated brain damage.
McDonald JW; Uckele J; Silverstein FS; Johnston MV
Neurosci Lett; 1989 Sep; 104(1-2):167-70. PubMed ID: 2682393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
